Agios Pharmaceuticals, Inc. (AGIO) — SC 13G/A Filings
All SC 13G/A filings from Agios Pharmaceuticals, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Vanguard Maintains 12.1% Stake in Agios Pharmaceuticals
— Feb 12, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Agios Pharmaceuticals Inc. As of Decemb -
Farallon Capital Exits Agios Pharma Stake as of Dec 31, 2023
— Feb 8, 2024 Risk: medium
Farallon Capital Partners, L.P. filed an amended SC 13G/A on February 8, 2024, indicating a change in their beneficial ownership of Agios Pharmaceuticals, Inc. -
BlackRock Amends Agios Pharma Stake, Signals Passive Investment
— Jan 25, 2024
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Common Stock in Agios Pharmaceuticals Inc. as of December 31, 2023. Th -
State Street Corp. Maintains Significant Stake in Agios Pharma
— Jan 22, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Agios Pharmaceuticals Inc. c
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX